It is with great pleasure that we have a special opportunity to post Dr. Steve Edelman & Dr. Jeremy Pettus's ADA recap from the recent ADA Scientific Sessions in Boston.
Today, we bring you the top ten list of comments we'd rather not hear, and some thoughts on how we might comment when we do hear them.
For those of us who use an insulin pump, changing out the insulin and tubing is one of the more time-consuming tasks we have to endure.
In early February Sanofi and MannKind announced the official launch of the ultra rapid-acting inhaled-insulin Afrezza. The insulin is now available at pharmacies nationwide.
When it comes to managing type-1 diabetes, insulin is no longer the only treatment option. Yes, insulin is necessary, but there are other injectable medications that can serve as powerful supplements to insulin. These medications can offer benefits to those trying to improve their after-meal glucose levels and/or shed unwanted pounds.
I recently read about FDA Approval for a “NEW” sugar substitute…Advantame. Interesting name – it would appear the creators believe there is an “advantage” to using it. The positive for people with diabetes of course, is that it doesn’t cause a glycemic response. Similar to the other sugar substitutes already on the market in a plethora of foods and beverages, Advantame is an artificial sweetener developed by the Japanese food and chemical corporation, Ajinomoto. Advantame is about 20,000 times sweeter than sucrose (table sugar). The FDA has approved it for general use in foods and beverages. This new artificial sweetener is also FEMA GRAS approved in Dairy, Frozen Desserts, Beverages, and Chewing Gum, but isn’t approved for use in products with meat or poultry. This is the 6th sweetener to be approved by the FDA and is a white powder derived from aspartame and vanillin that dissolves in water, and continues to remain stable in high temperatures (unlike pure aspartame which breaks down and doesn’t provide the taste appeal in baked products). Advantame's structure is chemically similar to aspartame, and it was assumed a warning label notifying people with phenylketonuria (PKU) to the presence of phenylalanine was required, but after further evaluation the agency determined that, since advantame is approximately 100 times sweeter than aspartame and requires only a fraction of the amount to achieve the same degree of sweetness, no warning label is necessary. This fact alone should make one consider the nature of the word artificial. We tend to rely heavily on products with no sugar when living with diabetes – but how much is too much and should we be considering these alternatives as good, bad or ugly? Looking at each artificial [...]
Vibe is the first and only insulin pump to integrate all the features of the Dexcom G4 display module into the pump itself. That’s right! No need to tote around a separate CGM display. I was given a 2-week trial/demo of the Vibe by Animas in mid-December, and promptly wore it on a one-week family cruise vacation and through the holidays. I must say, having the Dexcom CGM data right on the pump gave me a nice sense of autonomy.
When I hear the word “bionic,” I can’t help but have the opening theme of the 70s TV show “The Six Million Dollar Man” pop into my head. Then I come back to the 21st century, and ponder the exciting innovations of the bionic pancreas project.
These days, insulin pumps have sooooooo many features, it’s hard to pinpoint which one is truly best. Each pump has its share of strengths and weaknesses - So, keeping with our practice’s policy of keeping an open mind and offering up objective, practical information, we decided to put each pump’s bolus entry mechanism to the test.
Everyone needs an outlet for pent-up energy, frustration and negative emotions. I’m lucky enough to have two excellent catharsises (catharses? catharsisis? you get the idea): Exercise and writing.
If you have both diabetes and depression, you already know that it doesn’t feel good and you’d be better off if you could do something about it, right?
Poorly controlled diabetes (both type 1 and type 2) is a major risk factor for cardiovascular complications, and adults with diabetes are 2 to 4 times more likely than those without diabetes to suffer from heart disease or stroke.